The U.S. Food and Drug Administration (FDA) has announced a significant update to the labeling of all extended-release ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

For details on dosing in children, see the following section, “What’s the dosage of Botox for children?”. This dosing chart describes the usual doses of Botox given to adults during a single ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

The post Clindamycin Dosage Chart for Dogs: Risks, Side Effects, Dosage, and More appeared first on A-Z Animals. Sick dog Jack Russell Terrier waiting get pill from hand of owner or doctor.

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

Several pediatric cancer drugs are in shortage and others have been discontinued, according to the Food and Drug Administration. The most widely used of them is injectable methotrexate sodium, a ...

The Biden administration took steps to alleviate shortages of cancer drugs for children, part of a final push for one of the president’s domestic priorities: reducing the nation’s cancer burden.

Researchers have repurposed a generic drug, typically used for chemotherapy patients, to treat nonverbal children with autism. Dr. Richard Frye, who is driving research on the treatment of autism ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

At the same time, children who received the drug slowed weight gain to 1.6% of their body weight during that period, compared with a 10% gain for those who got sham drugs.

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma Theriva Biologics, Inc. Wed, Jul 31, 2024, 8:15 AM 4 min read ...